 |
|
|
| |
Retrospective Analysis of Clinical Characteristics and Treatment Patterns among HIV Patients with Commercial and Medicare Advantage Health Insurance in the US: high comorbidities & polypharmacy rates increasing with age
|
| |
| |
Soon death rates will increase. Jules
AGING EFFECT: 28% with depression on medicare vs 14% on commercial insurance.....70% on Medicare have CVD vs 34% on commercial insurance......22% have renal disease on Medicare vs 6% on commercial insurance.....hyperlipidemia on medicare is 56% vs 37% on commercial insurance
Common/select comorbidities in the overall study population included hyperlipidemia (41%), cardiovasculardisease (CVD,41%), hypertension (34%), depression (17%), AIDS (13%), renal disease (9%), and dementia(2%).
Prevalence of these common/select comorbidities were lower in treatment-naïve patients compared with treatment-experienced patients (hyperlipidemia [27% and 46%], CVD [31% and 44%], hypertension [25% and 37%], depression [12% and 18%], AIDS [15% and 12%], renal disease [5% and 10%], and dementia [1% and 2%]).
The mean (SD) daily pill burden for the overall patient population was 4.69 (5.9) pills/day for al medications 1.54 (1.9) pills/day for ART medications only and 3.15 (5.1) pills/day for non-ART medications only. Patients with Medicare insurance had a higher mean (SD) total daily pill burden (9.23[8.0] pills/day), than those with commercial insurance (3.68 [4.7] pills/day).
Reported by Jules Levin
IDWeek 2018™; October 3-7, 2018; San Francisco, CA
Julie Priest1, Tanya Burton2, Cori Blauer-Peterson3, Kate Andrade3, Alan Oglesby1
1ViiV Healthcare, Durham, NC, USA; 2OptumInsight, Boston, MA, USA; 3OptumInsight, Eden Prairie, MN, USA
|
| |
|
|
|
|
|
